Reactive oxygen species drives myocardial angiogenesis?

Antioxidants and Redox Signaling

Volumn 8, Issue 11-12, 2006, Pages 2161-2168

  Maulik, Nilanjana ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAREDOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; THIOREDOXIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; COLLATERAL CIRCULATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; ISCHEMIC PRECONDITIONING; LIMB ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SHORT SURVEY; ANIMAL; CORONARY BLOOD VESSEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

RATTUS;

ANIMALS; CORONARY VESSELS; HUMANS; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 33947679773     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.2161     Document Type: Short Survey

References (73)

1. Addya S, Shiroto K, Turoczi T, Zhan Lijun, Kaga S, Fukuda S, Surrey S, Duan Li-Juan, Fong G-H, Yamamoto F, and Maulik N. Ischemic preconditioning- mediated cardioprotection is disrupted in heterozygous Flt-1 (VEGFR-1) knockout mice. J Mol Cell Cardiol 38: 345-351, 2005.
2. Amer ESJ and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
3. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, and Isner JM. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 342-343, 1998.
4. Babior BM. The NADPH oxidase of endothelial cells. IUMB Life 50: 267-269, 2000.
5. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, and Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189, 1994.
6. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, and Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179, 1994.
7. Brand T, Sharma HS, Fleischmann KE, Duncker DJ, McFalls EO, Verdue PD, and Schaper W. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res 71: 1351-1360, 1992.
8. Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, and Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogens 15: 437-442, 1997.
9. Chinkers M and Garbers DL Signal transduction by guanylyl cyclases. Ann Rev Biochem 60: 553-575, 1991.
10. 2 in rat heart endothelial cells. Free Rad Biol Med 25: 891-897, 1998.
11. Crow JP. Dochlorodihydrofluorescein and dihydrorhodamine-123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1: 145-157, 1997.
12. Deramaudt BM, Braunstein S, Remy P, and Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 68: 121-127, 1998.
13. Donnini S and Ziche M. Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid Redox Signal 4: 817-823, 2002.
14. Ellis EA, Guberski DL, Somogyi-Mann M, and Grant MB. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 28: 91-101, 2000.
15. Ely SW and Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 85: 893-904, 1992.
16. Fong G-H, Rossant J, Gerstenstein M, and Breitman M L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995.
17. Fukuda S, Kaga S, Sasaki H, Zhan L, Zhu L, Otani H, and Maulik N. Angiogenesis signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol 36: 547-559, 2004.
18. Gallo O, Masini E, Morbidelli L, Franchi A, Finistorchi I, Vergari WA, and Ziehe M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596, 1998.
19. Hakada H, Inagaki M, Kawamoto S, and Sasaki, Y. Isoquinoline sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochem 23: 5036-5041 1984.
20. Hartnett ME, Garcia CM, and D'Amore PA. Release of bFGF, an endothelial cell survival factor, by osmotic shock. Invest Opthalmol Vis Sci 40: 2945-2951, 1999.
21. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, and Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in the rat heart. Am J Physiol 267: H1948-H1954, 1994.
22. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13963, 1989.
23. Isner J M, Pieczek A, Schainfed R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, and Symes J. Clinical evidence of angiogenesis is after arterial gene transfer of ph VEGF165 in patient with ischemic limb. Lancet 348: 370-374, 1996.
24. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, and Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396, 1995.
25. Jian Li, Brown LF. Hibberd MG. Grossman JD. Morgan JP, and Simon M. VEGF, Flk-1, Flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270: H1803-H1811, 1996.
26. Kaga S, Zhan I, Matsumoto M, and Maulik N. Resveratrol enhances neovascularization in the infracted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39: 813-822, 2005,
27. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, and Alitalo K. The related Flt-4, Flt-1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 178: 2077-2088, 1993.
28. Kwata H, Yoshida K-I, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyama T, Hashimoto T, and Dohi K. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 88: 696-704, 2001.
29. Ladoux A and Frelin C. Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem Biophys Res Commun 194: 799-803, 1993.
30. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, and Koch A. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91: 4190-4194, 1994.
31. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S, and Schmidt DH. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 454: 295-310, 1998.
32. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, and Simons M. VEGF, Flk-1, and Flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270: H1803-H1811, 1996.
33. Maulik N and Das DK. Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J Cell Mol Med 6: 13-24,2002.
34. Maulik N and Das DK. Redox signaling in vascular angiogenesis. Free Rad Biol Med 33: 1047-1060, 2002.
35. Maulik N, Engelman DT, Watanabe M, Engelman RM, Rousou JA, Flack JE, Deaton DW, Gorbunov NV, Elsayed NM, Kagan VE, and Das DK. Nitric oxide/carbon monoxide: a molecular switch for myocardial preservation during ischemia. Circulation 94: 398-406, 1996.
36. Maulik N, Engelman DT, Watanabe M, Engelman RM, and Das DK. Nitric oxide-a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem 157: 75-86, 1996.
37. Maulik N, Goswami S, Galang N, and Das DK. Differential regulation of Bcl-2, AP-1 and NF-κB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett 443: 331-336, 1999.
38. Maulik N. Redox regulation of vascular angiogenesis (forum editorial) Antioxid Redox Signal 4: 783-784, 2002.
39. Maulik N. Redox signaling of angiogenesis. Antioxid Redox Signal 4: 805-815, 2002.
40. Miller PD, Telford IR, and Haas GR. Effect of hyperbaric oxygen on cardiogenesis in the rat. Biol Neonute 17: 44-52, 1971.
41. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Anual Rev Immunol 15: 351-369, 1997.
42. Nakamura H, Vaage J, Valen G, Padilla CA., Bjornstedt M, and Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Rad Biol Med 24: 1176-1186, 1998.
43. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW, and Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1: 1085-1089, 1995.
44. Pipili-Synetos E, Papa Georglou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, and Maragoudakis ME Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 116: 1829-1834, 1995.
45. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, and Maragoudakis ME. Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994.
46. Quinn MT, Evans T, Loetterle LR, Jesaitis AJ, and Bokoch GM. Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 268: 20983-2097, 1993.
47. Ray PS, Estrada-Hernandez T, Sasaki H, Zhu Li, and Maulik N. Early effects of hypoxia/reoxygenation on VEGF, Ang-1, Ang-2 and their receptors in the rat myocardium: Implications for myocardial angiogenesis. Mol Cell Biochem 213: 145-153, 2000.
48. Ray PS, Sasaki H, Estrada-Hernandez T, Zhu Li, and Maulik N. Effects of hypoxia/reoxygenation on angiogenic factors and their tyrosine kinase receptors in the rat myocardium. Antoxid Redox Signal 3: 89-102, 2001.
49. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, and Kelly AB. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res 81: 24-33, 1997.
50. Sasaki H, Fukuda S, Otani H, Zhu Li, Yamaura G, Engelman RM, Das DK, and Maulik N. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction J Mol Cell Cardiol 34: 335-348, 2002.
51. Sasaki H, Ray PS, Zhu Li, Otani H, Asahara T,and Maulik N. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NFκB-dependent mechanism in a rat model of chronic myocardial infarction. J Mol Cell Cardiol 33: 283-294, 2001.
52. Schwarzacher S, Lim TT, Wang BY, Kernoff RS, Niebauer J, Cooke JP, and Yeung AC. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after vascular injury. Circulation 95: 1863-1869, 1997.
53. Semenza GL. HlF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480, 2000.
54. Sen CK, Khanna S, and Roy S. Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovasc Rex 71: 280-288, 2006
55. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, and Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376: 62-66, 1995.
56. Shih S-C, Mullen A, and Abrams K, Mukhopadhyay D, and Claffey KP. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol chem 274: 15407-15414, 1999.
57. Sogawa K, Numayama Tsuruta K, Ema M, Abe M, Abe H, and Fuji Kuriyama Y. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA 95: 7368-7373, 1998.
58. Spyridopoulos I, Brogi E, Kearney M, Sullivan AB, Cetrulo C, Isner JM, and Losardo DW. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals. J Mol Cell Cardiol 29: 1321-1330, 1997.
59. Takeshita S, Zheng LP, Brogi E, Kearney M, and Pu LQ. Therapeutic angiogenesis. A single intra arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670, 1994.
60. Takeya R, Ueno N, Kami K. Taura M, Kohjima M, Izaki T, Nunoi H, and Sumimoto H. Novel human homologues of p47phox and p67 phox participate in activation of superoxide-producing of NADPH oxidases. J Biol Chem 278: 25234-25246, 2003.
61. Terman BI, Vermazen MD, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, and Bohlen P. Identification of KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586, 1992.
62. Phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111: 2347-2355, 2005.
63. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, and Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3: 879-886, 1997.
64. Tuder RM. Voelkel NF, and Flook BE. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95: 1798-1807, 1995.
65. Tzeng E, Shears LL, Robbins PD, Pitt BR, Geller DA, Watkins SC, Simmons RI, and Billiar TR. Vascular gene transfer of the human inducible nitric oxide synthase characterization of activity and effects of myointimal hyperplasia. Mol Med 2: 211-225, 1996.
66. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, and Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141, 1995.
67. Welsh SJ, Bellamy WT, Briehl MM, and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1 alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 62: 5089-5095, 2002.
68. Welsh SJ, Williams RR, Birmingham A, Newman DJ, Kirkpatrick DL, and Powis G. The thioredoxin redox inhibitors 1-methyl-propyl 2- imidazolyl disulfide and pleurotin inhibit hypoxia induced factor 1 and vascular endothelial growth factor formation. Mol Cancer Ther 2: 235-243, 2003.
69. Witzenbichler B, Maisonpierre P C, Jones P, Yancopoulos GD, and Isner JM. Chemotactic properties of angiopoietin-1, angiopoietin-2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273: 18514-18521, 1998.
70. Woldbaek PR, Hoen, IB, Christensen G, and Tonnessen T. Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol Scand 175: 173-181, 2002.
71. Zhu Li, Fukuda S, Das DK, and Maulik N. Anti-apoptotic protein survivine plays a significant role in tubular morphogenesis of human arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 508: 369-374, 2001.
72. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, and Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.
73. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.